A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.
Ferrian, Selena
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis. [electronic resource] - PloS one 2017 - e0176660 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0176660 doi
Adult
Antitubercular Agents--therapeutic use
Biomarkers--blood
C-Reactive Protein--analysis
Chemokine CXCL10--blood
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Predictive Value of Tests
Serum Amyloid A Protein--analysis
Tuberculosis, Multidrug-Resistant--blood
Vascular Endothelial Growth Factor A--blood
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis. [electronic resource] - PloS one 2017 - e0176660 p. digital
Publication Type: Journal Article
1932-6203
10.1371/journal.pone.0176660 doi
Adult
Antitubercular Agents--therapeutic use
Biomarkers--blood
C-Reactive Protein--analysis
Chemokine CXCL10--blood
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Predictive Value of Tests
Serum Amyloid A Protein--analysis
Tuberculosis, Multidrug-Resistant--blood
Vascular Endothelial Growth Factor A--blood